Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

European Journal of Immunology

Volumn 33, Issue 1, 2003, Pages 119-124

  Bauernhofer, Thomas ^a   Kuss, Iris ^a   Henderson, Brent ^b   Baum, Andrew S ^b   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Annexin V; Apoptosis; Cytotoxicity; IL 2 receptor; NK cell

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CHROMIUM 51; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR; LIPOCORTIN 5;

ADULT; ANTIBODY DETECTION; APOPTOSIS; BINDING AFFINITY; BREAST CANCER; CANCER PATIENT; CELL ASSAY; CELL STRAIN K 562; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; RADIOASSAY; REVIEW; STAINING; TARGET CELL; AGED; ARTICLE; CELL CULTURE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEOPLASM; PATHOLOGY;

ADULT; AGED; ANNEXIN A5; ANTIGENS, CD56; APOPTOSIS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEOPLASMS; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-2; TUMOR CELLS, CULTURED;

EID: 0037208228     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200390014     Document Type: Review

References (15)

1. Whiteside, T. L. and Herberman, R. B., The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 1995. 7: 704-710.
2. Takeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H. and Okumura, K., Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 2001. 7: 94-100.
3. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-40.
4. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M. and Lopez Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
5. + T lymphocytes in peripheral blood of patients with advanced melanoma. Clin. Cancer Res. 2000. 6: 1351-1364.
6. + peripheral blood T lymphocytes of patients with melanoma. Clin. Cancer Res. 2001. 7: 947s-957s.
7. Kuss, I., Saito, T., Johnson, J. T. and Whiteside, T. L., Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin. Cancer Res. 1999. 5: 329-334.
8. Steinhauer, E. H., Doyle, A. T., Reed, J. and Kadish, A. S., Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon. J. Natl. Cancer Inst. 1985. 75: 1017-1023.
9. Gastl, G., Niederwieser, D., Marth, C., Huber, H., Egg, D., Schuler, G., Margreiter, R., Braunsteiner, H. and Huber, C., Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 1984. 64: 288-295.
10. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191.
11. dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 1996. 88: 2279-87.
12. Lucia, B., Jennings, C., Cauda, R., Ortona, L. and Landay, A. L., Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry 1995. 22: 10-15.
13. Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A. and Ritz, J., Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 1990. 171: 1509-1526.
14. Carson, W. E., Haldar, S., Baiocchi, R. A., Croce, C. M. and Caligiuri, M. A., The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc. Natl. Acad. Sci. USA 1994. 91: 7553-7557.
15. Friberg, D. D., Bryant, J. L. and Whiteside, T. L., Measurements of natural killer (NK) activity and NK-cell quantification. Methods 1996. 9: 316-326.